18 results
6-K
EX-99.1
BLRX
Bioline Rx Ltd
17 Apr 24
BioLineRx Announces Poster Presentation on Apheresis Center Efficiency and CXCR4
7:12am
can cause fetal harm. Advise pregnant women of the potential risk to the fetus. Verify pregnancy status in females of reproductive potential prior
6-K
EX-1
BLRX
Bioline Rx Ltd
16 Feb 24
Current report (foreign)
7:07am
women of the potential risk to the fetus. Verify pregnancy status in females of reproductive potential prior to initiating treatment with APHEXDA
6-K
EX-99
BLRX
Bioline Rx Ltd
11 Sep 23
BioLineRx Announces FDA Approval of APHEXDA™ (motixafortide) in Combination with Filgrastim (G-CSF) to Mobilize Hematopoietic Stem Cells for Collection and Subsequent Autologous Transplantation in Patients with Multiple
7:07am
cause fetal harm. Advise pregnant women of the potential risk to the fetus. Verify pregnancy status in females of reproductive potential prior
20-F/A
8vmj jmg6q7zk
23 Mar 15
Annual report (foreign) (amended)
12:00am
424B3
2nrcd xrshr8wb
8 Aug 13
Prospectus supplement
12:00am
424B3
sxekpfysl9pe0g
15 Oct 12
Prospectus supplement
12:00am
F-1
n6pgn 3wa
2 Oct 12
Registration statement (foreign)
12:00am
424B3
psby2xvy
28 Mar 12
Prospectus supplement
12:00am
20-F
0yyp8xg6ni9
22 Mar 12
Annual report (foreign)
12:00am
20FR12B/A
h6tkohti
15 Jul 11
Initial registration of securities (foreign private issuers) (amended)
12:00am
20FR12B
ek7ufog4qmnlm
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am
20FR12B
EX-4.17
n1pxu66ryzv
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am
F-1
hcra6p3a2cc8
24 Sep 10
Registration statement (foreign)
12:00am
F-1
EX-10.17
ofht lsevd89u
24 Sep 10
Registration statement (foreign)
12:00am
- Prev
- 1
- Next